Model Compares Post-Kidney Transplant Drug Regimens
Calcineurin inhibitor withdrawal regimen linked to better long-term patient survival, lower cost
Publish date: June 19, 2008
A calcineurin inhibitor (CNI) withdrawal regimen for de novo kidney transplant patients was associated with better long-term patient and graft survival, compared with common CNI-containing immunosuppressive therapies, according to research published online June 18 in the Journal of the American Society of Nephrology.